Health
FDA considers gene therapy to treat rare muscle disease
A drug maker is seeking FDA approval to treat a rare form of muscular dystrophy with what would be the first gene therapy green-lighted through the agency’s accelerated approval process.
Top Stories
Just the News Spotlight
Just News, No Noise
Trending
- Biden employs 152 more White House staffers than Trump in final year, annual budget $60.8M: watchdog
- Hamas approves ceasefire deal, but demands 'written guarantees' for Israel negotiations
- You Vote: Do you think that Biden's ABC interview helped his campaign?
- Moderate wins Iran’s presidential race, promises to warm relations with West
- Biden says Trump's 'shouting' distracted him during the debate, despite no proof it occurred